The Chinese pharmaceutical company Zhejiang Hisun Pharmaceutical began production of the first drug that could fight the coronavirus, after last February 15th received the official endorsement of the National Food and Drug Administration to go to market.
According to the administration of the city of Taizhou, east of China, the drug was formerly known as Favipiravir or Avigan and It is the first medicine included in the list of drugs that can be effective in the treatment of the disease.
On February 15, the director of the National Biotechnology Center of China, Zhang Xinmin, announced that some antiviral medications, including chloroquine phosphate, favipiravir and remdesivir, were undergoing clinical trials against the new pneumonia coronavirus
Chinese scientists use different technologies to accelerate the development of a vaccine against the new coronavirus and several vaccines are already being tested in animals.
The other drugs tested are chloroquine phosphate, used to fight malaria, and remdesivir, created to fight Ebola. They inhibited the development of the virus at the cellular level and there has been an improvement in patients to whom the drugs were administered.